Medtronic Launches 722 Real-time Insulin Pump System In China
This article was originally published in PharmAsia News
Executive Summary
Medtronic (Shanghai) Management Co., Ltd. has launched its 722 Real-time Insulin Pump System in China.
Medtronic (Shanghai) Management Co., Ltd. has launched its 722 Real-time Insulin Pump System in China. According to an expert, the system shows the patient’s latest blood sugar information constantly collected through an implanted subcutaneous glucose probe and gives a warning when it is below a preset level for insulin. It also provides analysis of multiple data including blood sugar levels, insulin dosages, and carbohydrate intake. A registered clinical study shows that the system’s blood sugar information accuracy rate exceeds 99%. It will soon be used in large hospitals in China. (Click Here For More - Chinese Language
)
"First Step Towards Human Insulin; Medtronic’s 722 Real-time Insulin Pump System Launched In China" - smianet.com (8/1/2012)